vancomycin has been researched along with glucagon-like peptide 1 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hwang, I; Ka, S; Kim, JB; Kim, YN; Kim, YR; Lee, HY; Park, YJ; Seok, YJ; Seong, JK | 1 |
| Fukui, H; Miwa, H; Oshima, T; Ran, Y; Tomita, T; Watari, J; Xu, X | 1 |
| Altindis, E; Blaak, EE; Canfora, EE; Cederquist, C; Dirice, E; Figura, M; Fujisaka, S; Girdhar, K; Goossens, GH; Hu, J; Huang, Q; Kahn, CR; Kulkarni, RN; Orliaguet, L; Raisingani, A; Soto, M; Sundaresh, B | 1 |
3 other study(ies) available for vancomycin and glucagon-like peptide 1
| Article | Year |
|---|---|
Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity.
Topics: Animals; Anti-Bacterial Agents; Bacitracin; Bacteroidetes; Blood Glucose; Blotting, Western; Cell Line, Tumor; Diet, High-Fat; Gastrointestinal Tract; Glucagon-Like Peptide 1; Gram-Positive Bacteria; Humans; Insulin; Insulin Resistance; Metabolomics; Mice, Inbred C57BL; Microbiota; Obesity; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Vancomycin | 2015 |
Alteration of GLP-1/GPR43 expression and gastrointestinal motility in dysbiotic mice treated with vancomycin.
Topics: Animals; Body Weight; Dysbiosis; Female; Gastrointestinal Microbiome; Gastrointestinal Motility; Gastrointestinal Tract; Glucagon-Like Peptide 1; Mice; Receptors, G-Protein-Coupled; Vancomycin | 2019 |
Gut Microbiota Regulate Pancreatic Growth, Exocrine Function, and Gut Hormones.
Topics: Amylases; Animals; Diet, High-Fat; Gastrointestinal Microbiome; Glucagon-Like Peptide 1; Humans; Mice; Mice, Inbred C57BL; Obesity; Pancreas; Pancreatic Elastase; Vancomycin | 2022 |